Ex Hollyoaks star Emmett Scanlan joins BBC3's In the Flesh

Emmett J Scanlan has started filming on BBC Three zombie drama In The Flesh.

The Fall and Hollyoaks actor has joined the cast of the BBC Three show for its second series, playing a disciple of the Undead Prophet, Simon.

In The Flesh follows Kieren, played by Luke Newberry, who has Partially Deceased Syndrome and is struggling to find acceptance in his home town of Roarton.

The new series sees him struggling to escape Roarton, while the rise of Pro-Living Party Victus sparks a spate of terrorism linked to the Undead Liberation Army.

Director Jim O'Hanlon said: "With its uniquely naturalistic take on the zombie genre, told as much from the point of view of the zombies or PDS sufferers themselves, as that of the locals forced to live alongside them, In The Flesh is original, dramatic, funny, politically engaged and never less than 100 per cent emotionally truthful.

"It's rare to find a series that is so exciting, entertaining and humorous, and yet has so much to say about the world we live in today. The characters have genuine verve, wit, colour and depth and I can't wait to get started on bringing them to life."

Emmett recently tweeted that he would be starting work on the second series of serial killer thriller The Fall early next year.

 

Patrick McLennan

Patrick McLennan is a London-based journalist and documentary maker who has worked as a writer, sub-editor, digital editor and TV producer in the UK and New Zealand. His CV includes spells as a news producer at the BBC and TVNZ, as well as web editor for Time Inc UK. He has produced TV news and entertainment features on personalities as diverse as Nick Cave, Tom Hardy, Clive James, Jodie Marsh and Kevin Bacon and he co-produced and directed The Ponds, which has screened in UK cinemas, BBC Four and is currently available on Netflix. 


An entertainment writer with a diverse taste in TV and film, he lists Seinfeld, The Sopranos, The Chase, The Thick of It and Detectorists among his favourite shows, but steers well clear of most sci-fi.